true

Simon Fleming

Veteran of the pharmaceutical industry, fluent in all aspects of clinical trial management, including business development, strategic operations, process improvement, technology implementation and finance. Special focus on global quality management, data management, biostatistics and statistical programming operations.

• Read: Precision for Medicine Re-approved as a CIR-Eligible R&D Partner Under the French Research Tax Credit Programme

  Precision for Medicine Re-approved as a CIR-Eligible R&D Partner Under the French Research Tax Credit Programme

  Oct 21, ‘26 | 2 min read

  • 

    Angelique Heckmann, PhD

  Discover
• Read: The Cells Don't Have to Be Alive: Immunophenotyping post CAR-T Therapy

  The Cells Don't Have to Be Alive: Immunophenotyping post CAR-T Therapy

  Oct 20, ‘26 | 4 min read

  • 

    Sven Olek, PhD

  Discover
• Read: Why In-Country Project Management Is a Non-Negotiable in APAC Trials

  Clinical Trials

  Why In-Country Project Management Is a Non-Negotiable in APAC Trials

  Oct 19, ‘26 | 7 min read

  • 

    Hannah Urbanski

  Discover
• Read: The Operational Reality of Clinical Trial Technology

  Clinical Trials

  The Operational Reality of Clinical Trial Technology

  Oct 12, ‘26 | 8 min read

  • 

  • Sadie O.

    Jennifer W.

  Discover
• Read: Case Study: FIH Radiopharmaceutical Trial Across South Korea and US

  Oncology

  Case Study: FIH Radiopharmaceutical Trial Across South Korea and US

  Oct 05, ‘26 | 7 min read

  • 

    Tai Bibbs

  Discover
• Read: Case Study: Global Phase 2 Drug Delivery in Advanced Colorectal Cancer

  Oncology

  Case Study: Global Phase 2 Drug Delivery in Advanced Colorectal Cancer

  Sep 28, ‘26 | 9 min read

  • 

    Tai Bibbs

  Discover
• Read: Case Study: Managing Complexity in an Autologous Cell Therapy Trial

  Clinical Trials

  Case Study: Managing Complexity in an Autologous Cell Therapy Trial

  Sep 22, ‘26 | 8 min read

  • 

  • Deborah S.

    Saoussen B.

    Jack S.

  Discover
• Read: How Investigator Engagement Builds Enrollment Momentum

  Clinical Trials

  How Investigator Engagement Builds Enrollment Momentum

  Sep 21, ‘26 | 6 min read

  • 

    Lisa Lopez

  Discover
• Read: Case Study: Nectin 4 Biomarker Testing for Oncology Clinical Programs

  Translational Research

  Case Study: Nectin 4 Biomarker Testing for Oncology Clinical Programs

  Sep 14, ‘26 | 3 min read

  • 

    Christie Bongel

  Discover
• Read: Has the rest of the world finally caught up with Latin America?

  Clinical Trials

  Has the rest of the world finally caught up with Latin America?

  Sep 02, ‘26 | 5 min read

  • 

    Andrés Bayona

  Discover
• Read: Case Study: Rapid Execution of Assay Validation Rescued Global Study

  Translational Research - Assays

  Case Study: Rapid Execution of Assay Validation Rescued Global Study

  Aug 20, ‘26 | 7 min read

  • 

  • Christie B.

    Kennon D.

  Discover
• Read: Clinical AI at Scale: Why Trust Matters More Than Speed

  Clinical Trials

  Clinical AI at Scale: Why Trust Matters More Than Speed

  Aug 18, ‘26 | 6 min read

  • 

  • Zulfat K.

    Shakila J.

    Sugumaran M.

  Discover
• Read: Hidden Strategic Edge in Clinical Trials: Financial Project Management

  Clinical Trials

  Hidden Strategic Edge in Clinical Trials: Financial Project Management

  Aug 17, ‘26 | 5 min read

  • 

    Romy Kane

  Discover
• Read: Why Most Early Autoimmune Trials Fail to Yield Decision-ready Evidence

  Early Phase Research - Autoimmune

  Why Most Early Autoimmune Trials Fail to Yield Decision-ready Evidence

  Aug 10, ‘26 | 6 min read

  • 

    Rui F Duarte-Lopes

  Discover
• Read: Why Global Oncology Evidence May Not Support U.S. Regulatory Approval

  Clinical Trials - Regulatory

  Why Global Oncology Evidence May Not Support U.S. Regulatory Approval

  Aug 03, ‘26 | 9 min read

  • 

    Harpreet Singh, MD

  Discover
• Read: Early-Phase Oncology Trials in Ireland: Why START Dublin Is a High-Performing Site for Sponsors

  Clinical Trials

  Early-Phase Oncology Trials in Ireland: Why START Dublin Is a High-Performing Site for Sponsors

  Aug 03, ‘26 | 10 min read

  • 

    Deana Demjen

  Discover
• Read: Receptor Occupancy in the Era of Multispecific Therapeutics

  Translational Research - Lab Services

  Receptor Occupancy in the Era of Multispecific Therapeutics

  Jul 28, ‘26 | 6 min read

  • 

  • Deborah P.

    Jenny Z.

  Discover
• Read: Case Study: Prescreening Intel Restores Phase 3 Colorectal Enrollment

  Case Study: Prescreening Intel Restores Phase 3 Colorectal Enrollment

  Jul 27, ‘26 | 8 min read

  • 

    Erica Donnelly

  Discover

Loading...

You've reach the end Back to top